Back to Trades
Tyndall Mark Anthony
EVP & CLO and Corp SecCIK 0001944622
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Tyndall Mark Anthony, EVP & CLO and Corp Sec, has disclosed $0 in transactions — all concentrated in Keenova Therapeutics plc (NONE). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Feb 26 | NONE Keenova Therapeutics plc | Tyndall Mark Anthony | EVP & CLO and Corp Sec | Award | $0 |
| Jan 5 | NONE Keenova Therapeutics plc | Tyndall Mark Anthony | EVP & CLO and Corp Sec | Exercise | $0 |
| Aug 4 | NONE Mallinckrodt plc | Tyndall Mark Anthony | EVP & CLO and Corp Sec | Award | $0 |
3 filings